Filter by: Reset All
- Showing 15151 - 15165 of 19776 results (Page 1011)
- Sort by
-
The ChemOthersapy-Induced Neutropenia Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for ChemOthersapy-Induced Neutropenia Treatment is projected to grow from US$ xx million...$0Read More
-
The Artificial Disc market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Artificial Disc is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at...$0Read More
-
The Medical Anesthesia Machines market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Medical Anesthesia Machines is projected to grow from US$ xx million in 2020, and is projected...$0Read More
-
The Follicular Thyroid Cancer Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Follicular Thyroid Cancer Drug is projected to grow from US$ xx million in 2020, and is projected...$3,360Read More
-
The Anterior Uveitis Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Anterior Uveitis Drug is projected to grow from US$ xx million in 2020, and is projected to reach xx...$0Read More
-
The Laryngoscope Handle market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Laryngoscope Handle is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025,...$3,360Read More
-
The Fibrinogen Deficiency Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Fibrinogen Deficiency Drug is projected to grow from US$ xx million in 2020, and is projected to...$3,360Read More
-
The Pyrazinamide market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Pyrazinamide is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR...$3,360Read More
-
The Healthcare Robotics market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Healthcare Robotics is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025,...$0Read More
-
The Computer Workstation market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Computer Workstation is projected to grow from US$ xx million in 2020, and is projected to reach xx by...$0Read More
-
The Renal Anemia Therapeutics market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Renal Anemia Therapeutics is projected to grow from US$ xx million in 2020, and is projected to reach...$3,360Read More
-
The Small Interfering RNA (siRNA) Therapeutics market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Small Interfering RNA (siRNA) Therapeutics is projected to grow from US$ xx million...$0Read More
-
The Suprapubic Catheter market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Suprapubic Catheter is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025,...$3,360Read More
-
The Nicotine Addiction Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Nicotine Addiction Treatment is projected to grow from US$ xx million in 2020, and is projected...$3,360Read More
-
The Gemcitabine (CAS 95058-81-4) market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Gemcitabine (CAS 95058-81-4) is projected to grow from US$ xx million in 2020, and is projected...$3,360Read More
Our Clients
